eMagin Corporation provided earnings guidance for the second quarter of 2022. For the quarter, the company expected revenue to be between $7.0 million to $7.2 million, which would represent an 11% to 14% increase from revenues of $6.3 million for the second quarter of 2021. The estimated improvement in year-over-year revenues reflects strength in military demand as well as increased revenue contributions from medical customers, partially offset by decreases in contract revenue related to the timing of development activities.